CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 17 enrolled
Drug / intervention
Vagus Nerve Stimulation (VNS)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02243020
NCT02243020N/ACompleted

Study MT-St-02 - Stroke - A Randomized Pilot Study Assessing Vagus Nerve Stimulation (VNS) During Rehabilitation for Improved Upper Limb Motor Function After Stroke (MicroTransponder's Vivistim System)

MicroTransponder Inc.·interventional·Posted Sep 17, 2014·Updated Sep 15, 2022

In Brief

A clinical study evaluating Vagus Nerve Stimulation (VNS) for Stroke and Upper Limb Deficits. Completed, enrolled 17 participants across 3 sites.

Detailed Summary

The primary study objectives are to assess the safety and feasibility of the therapy, including the surgical intervention and stimulation, as well as to provide information on the appropriateness of the study test measures (assessments) and to provide a basis for sample size calculations for a larger, pivotal study.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedSep 17, 2014
Enrollment StartOct 1, 2014
Primary CompletionDec 1, 2016
Study CompletionJun 1, 2022
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 11.8 years ago

Interventions

Vagus Nerve Stimulation (VNS)device